Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Liheng Ma
Prevalence of ROS1 Fusion in Chinese Patients With Non-Small Cell Lung Cancer
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology
Related publications
Clinicopathological Features and Clinical Efficacy of Crizotinib in Chinese Patients With ROS1‑positive Non‑small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non–Small Cell Lung Cancer Patient
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
HER2 Mutations in Chinese Patients With Non-Small Cell Lung Cancer
Oncotarget
Oncology
Clinical Features of Bim Deletion Polymorphism and Its Relation With Crizotinib Primary Resistance in Chinese Patients With ALK /ROS1 Fusion-Positive Non-Small Cell Lung Cancer
Cancer
Cancer Research
Oncology
ROS1 Immunohistochemistry Among Major Genotypes of Non–Small-Cell Lung Cancer
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
P2.01-50 Thromboembolism in ROS1 Rearranged Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA09 Preliminary Clinical Activity of Repotrectinib (TPX-0005) in Advanced ROS1 Fusion-Positive Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.03-02 Analysis of SMAD4 Aberrations in Chinese Patients With Non-Small-Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Clinicopathological Characteristics and Survival of ALK, ROS1 and RET Rearrangements in Non-Adenocarcinoma Non-Small Cell Lung Cancer Patients
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
